ABBV241129P210000
- 22.40
- 0.000.00%
AbbVie Newsroom
S&P 500 and Nasdaq Hit Closing and Trading Highs Monday | Wall Street Today
Why Dividend Aristocrats Like Walmart, ADP, and AbbVie Are Set to Outperform -- Barrons.com
December Starts With a Mixed Market | Live Stock
Satellos to Participate in Duchenne KOL Investor Webinar on December 4, 2024
Spotlight on AbbVie: Analyzing the Surge in Options Activity
Catalyst Watch: November Jobs, OPEC+ Meeting, Marvell, Salesforce Earnings
Why Is AbbVie (ABBV) Down 10.2% Since Last Earnings Report?
With 73% Ownership in AbbVie Inc. (NYSE:ABBV), Institutional Investors Have a Lot Riding on the Business
Why AbbVie Inc. (ABBV) Is One of the Most Undervalued Pot Stocks to Buy?
Wednesday Ends With Index Decline | Wall Street Today
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
Unusual Options Activity: EDR, BBD and Others Attract Market Bets, EDR V/OI Ratio Reaches 174.3
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Alector/AbbVie-Partnered Alzheimer's Drug Disappoints In Mid-Stage Study; Alector Lays Off 17% Of Workforce
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
(ABBV) - Analyzing AbbVie's Short Interest
Is AbbVie Inc. (ABBV) the Best Dividend Aristocrat Stock To Buy Right Now?
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
Market Whales and Their Recent Bets on ABBV Options
S&P 500, Dow Hit Records Right After Open | Live Stock